Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Flurbiprofen transdermal - Tokuhon Corporation

X
Drug Profile

Flurbiprofen transdermal - Tokuhon Corporation

Alternative Names: Fulruban Pap; Stayban® Pap; Yakuban Tape

Latest Information Update: 12 Jan 2022

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Tokuhon Corporation
  • Developer GC-Rise Pharmaceutical; Taisho Toyama Pharmaceutical; Tokuhon Corporation; Tokyo Medical and Dental University
  • Class Antipyretics; Antirheumatics; Nonsteroidal anti-inflammatories; Propionic acids
  • Mechanism of Action Cyclooxygenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Inflammatory pain; Muscle pain; Musculoskeletal disorders; Osteoarthritis; Periarthritis; Tendinitis
  • No development reported Pain

Most Recent Events

  • 28 Feb 2020 No recent reports of development identified for clinical-Phase-Unknown development in Osteoarthritis in Japan (PO)
  • 09 Nov 2018 Taisho Toyama Pharmaceutical and Tokyo Medical and Dental University complete a clinical trial in Osteoarthritis in Japan (PO) (UMIN000024789)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top